Dr. Scott Gottlieb

Deconstructing FDA’s Mixed Bag Approach to Stem Cell Clinics

FDA-draft-guidance

In a nutshell, what does all of this week’s big FDA developments on stem cells and regenerative medicine mean for stem cell clinics? There’s much to be upbeat about so overall I’d say it’s good news, but I see three significant potential problems too. Dang. The good news is that the FDA seems determined to …

Deconstructing FDA’s Mixed Bag Approach to Stem Cell Clinics Read More »

Reading the tea leaves as new FDA commish Gottlieb blogs on regenerative medicine

Dr.-Scott-Gottlieb

New FDA Commissioner Dr. Scott Gottlieb, M.D., has in the past touched on stem cells and regenerative medicine therapies in speeches or written comments prior to starting his tenure at the agency. Now that he is Commissioner, he is poised to have direct impact on our field rather quickly and potentially with major changes in …

Reading the tea leaves as new FDA commish Gottlieb blogs on regenerative medicine Read More »